Global ctDNA Methylation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global ctDNA Methylation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
ctDNA methylation refers to the analysis of DNA methylation patterns in circulating tumor DNA (ctDNA), which are fragments of DNA released into the bloodstream by tumor cells. DNA methylation is an essential epigenetic modification that involves the addition of a methyl group to the DNA molecule, typically occurring at cytosine residues within CpG dinucleotides.
ctDNA Methylation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global ctDNA Methylation market is projected to reach US$ 237.8 million in 2029, increasing from US$ 86 million in 2022, with the CAGR of 14.9% during the period of 2024 to 2029. Demand from Hospital and Third Party Organization are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for ctDNA Methylation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, ctDNA Methylation key companies include New Horizon Health Limited, genetronhealth, Burning Rock Biotech, BGI, Amoy Diagnostics Co, Singlera and Phalanx Biotech, etc. New Horizon Health Limited, genetronhealth, Burning Rock Biotech are top 3 players and held % share in total in 2022.
ctDNA Methylation can be divided into Based on Restriction Enzyme, Based on Affinity Enrichment and Based on Bisulfite,, etc. Based on Restriction Enzyme is the mainstream product in the market, accounting for % share globally in 2022.
ctDNA Methylation is widely used in various fields, such as Hospital, Third Party Organization and Other,, etc. Hospital provides greatest supports to the ctDNA Methylation industry development. In 2022, global % share of ctDNA Methylation went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global ctDNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
New Horizon Health Limited
genetronhealth
Burning Rock Biotech
BGI
Amoy Diagnostics Co
Singlera
Phalanx Biotech
Segment by Type
Based on Restriction Enzyme
Based on Affinity Enrichment
Based on Bisulfite
Hospital
Third Party Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the ctDNA Methylation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, ctDNA Methylation introduction, etc. ctDNA Methylation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of ctDNA Methylation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
ctDNA Methylation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global ctDNA Methylation market is projected to reach US$ 237.8 million in 2029, increasing from US$ 86 million in 2022, with the CAGR of 14.9% during the period of 2024 to 2029. Demand from Hospital and Third Party Organization are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for ctDNA Methylation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, ctDNA Methylation key companies include New Horizon Health Limited, genetronhealth, Burning Rock Biotech, BGI, Amoy Diagnostics Co, Singlera and Phalanx Biotech, etc. New Horizon Health Limited, genetronhealth, Burning Rock Biotech are top 3 players and held % share in total in 2022.
ctDNA Methylation can be divided into Based on Restriction Enzyme, Based on Affinity Enrichment and Based on Bisulfite,, etc. Based on Restriction Enzyme is the mainstream product in the market, accounting for % share globally in 2022.
ctDNA Methylation is widely used in various fields, such as Hospital, Third Party Organization and Other,, etc. Hospital provides greatest supports to the ctDNA Methylation industry development. In 2022, global % share of ctDNA Methylation went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global ctDNA Methylation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
New Horizon Health Limited
genetronhealth
Burning Rock Biotech
BGI
Amoy Diagnostics Co
Singlera
Phalanx Biotech
Segment by Type
Based on Restriction Enzyme
Based on Affinity Enrichment
Based on Bisulfite
Segment by Application
Hospital
Third Party Organization
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the ctDNA Methylation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, ctDNA Methylation introduction, etc. ctDNA Methylation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of ctDNA Methylation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices